Pandite Arundathy N. 4
4 · Shattuck Labs, Inc. · Filed Jan 13, 2026
Insider Transaction Report
Form 4
Pandite Arundathy N.
Chief Medical Officer
Transactions
- Tax Payment
Common Stock
2026-01-10$4.75/sh−6,851$32,542→ 199,414 total - Award
Common Stock
[F1]2026-01-10+487,800→ 487,800 totalExercise: $4.75Exp: 2036-01-10→ Common Stock (487,800 underlying)
Footnotes (1)
- [F1]This option represents a right to purchase a total of 487,800 shares of the Issuer's common stock, one quarter of which will vest on January 10, 2027, with the remaining three quarters vesting in equal monthly installments through January 10, 2030, subject to the Reporting Person's continued service to the Issuer.
Signature
/s/ Andrew R. Neill, Attorney-in-fact for Arundathy N. Pandite|2026-01-13